Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts

HIV Infection

Free Subscription Articles published in JAMA Retrieve available abstracts of 27 articles: HTML format

Single Articles

March 2025
1. SPINELLI MA, Heise MJ, Gistand N, Cox C, et al
   HIV Viral Suppression With Use of Long-Acting Antiretroviral Therapy in People With and Without Initial Viremia.
   JAMA. 2025 Mar 6. doi: 10.1001/jama.2025.0109.
   PubMed    
   
   
   February 2025
2. SEAS C, Seas PR, Legua P
   A 25-Year-Old With Verrucous Pustules and Fevers.
   JAMA. 2025 Feb 27. doi: 10.1001/jama.2024.28032.
   PubMed    
   
   
   
3. APPA A, Spinelli MA, Javanbakht M, Heise MJ, et al
   Unintentional Fentanyl Use Detected in Hair of People With HIV Risk Using Methamphetamine.
   JAMA. 2025 Feb 26:e2428618. doi: 10.1001/jama.2024.28618.
   PubMed    
   
   
   January 2025
4. ANDERER S
   Twice-Yearly Lenacapavir Could Support HIV Prevention in Vulnerable Populations.
   JAMA. 2025 Jan 3. doi: 10.1001/jama.2024.26876.
   PubMed    
   
   
   December 2024
5. DEL RIO C, Dzau V
   The Urgent Case for Recommitting to Global HIV/AIDS Goals.
   JAMA. 2024 Dec 10. doi: 10.1001/jama.2024.26348.
   PubMed    
   
   
   
6. GANDHI RT, Landovitz RJ, Sax PE, Smith DM, et al
   Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.
   JAMA. 2024 Dec 1. doi: 10.1001/jama.2024.24543.
   PubMed     Abstract available
   
   
   
7. MARKS KM, Kang M, Umbleja T, Cox A, et al
   HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial.
   JAMA. 2024 Dec 1:e2424490. doi: 10.1001/jama.2024.24490.
   PubMed     Abstract available
   
   
   
8. HATLEN TJ, Bender Ignacio R, Daar ES
   Advances in Treatment and Prevention of HIV.
   JAMA. 2024 Dec 1. doi: 10.1001/jama.2024.24027.
   PubMed    
   
   
   
9. NIU X, Drain PK
   Is Lenacapavir Needed for Individuals Adherent to Daily Oral PrEP?
   JAMA. 2024 Dec 1. doi: 10.1001/jama.2024.22995.
   PubMed    
   
   
   October 2024
10. PALEFSKY JM
    Prevention of Anal Cancer in High-Risk Individuals.
    JAMA. 2024 Oct 23. doi: 10.1001/jama.2024.17870.
    PubMed    
    
    
    
11. MANN LM, Zhu W, Huang YA, Kourtis AP, et al
    Trends in Oral and Injectable HIV Preexposure Prophylaxis Prescriptions in the US, 2013-2023.
    JAMA. 2024 Oct 14. doi: 10.1001/jama.2024.21493.
    PubMed    
    
    
    
12. TITANJI BK, Hazra A, Zucker J
    Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review.
    JAMA. 2024 Oct 14. doi: 10.1001/jama.2024.21091.
    PubMed     Abstract available
    
    
    
13. SPINELLI MA, Ngure K, Gandhi M
    Preexposure Prophylaxis (PrEP) for HIV.
    JAMA. 2024 Oct 14. doi: 10.1001/jama.2024.16984.
    PubMed    
    
    
    September 2024
14. MALANI P
    Thirty-Five Years of HIV Research in Africa-An Interview With Winners of the 2024 Lasker-Bloomberg Public Service Award.
    JAMA. 2024 Sep 19. doi: 10.1001/jama.2024.19030.
    PubMed    
    
    
    July 2024
15. SCHRIER E, Schwartz HEM, Himmelstein DU, Gaffney A, et al
    Hospital Assets Before and After Private Equity Acquisition.
    JAMA. 2024 Jul 30:e2413555. doi: 10.1001/jama.2024.13555.
    PubMed    
    
    
    June 2024
16. HARRIS E
    AAP Changes Its Breastfeeding Policy for People With HIV in US.
    JAMA. 2024 Jun 14. doi: 10.1001/jama.2024.10335.
    PubMed    
    
    
    
17. PIRRACCHIO R, Venkatesh B, Legrand M
    Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review.
    JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.6096.
    PubMed     Abstract available
    
    
    May 2024
18. HARRIS E
    CDC Warns of Surge in Meningococcal Disease in US.
    JAMA. 2024;331:1614.
    PubMed    
    
    
    
19. MCKENNA M
    Produce Prescriptions Sound Good, but Data to Support Them Are Lacking-That Could Soon Change.
    JAMA. 2024;331:1433-1436.
    PubMed    
    
    
    April 2024
20. HARRIS E
    WHO Documents Rising Resistance to First-Line HIV Drug.
    JAMA. 2024 Apr 5. doi: 10.1001/jama.2024.4497.
    PubMed    
    
    
    March 2024
21. STOOPLER ET, Villa A, Bindakhil M, Diaz DLO, et al
    Common Oral Conditions: A Review.
    JAMA. 2024;331:1045-1054.
    PubMed     Abstract available
    
    
    
22. SHETH AN, Momplaisir F, Dumond JB
    Shifting the Narrative of Preexposure Prophylaxis Adherence Counseling for Cisgender Women.
    JAMA. 2024;331:912-914.
    PubMed    
    
    
    
23. PECK RN, Issarow B, Kisigo GA, Kabakama S, et al
    Linkage Case Management and Posthospitalization Outcomes in People With HIV: The Daraja Randomized Clinical Trial.
    JAMA. 2024 Mar 6:e242177. doi: 10.1001/jama.2024.2177.
    PubMed     Abstract available
    
    
    
24. AMICO KR
    A Linkage-to-Care Intervention for Hospitalized People With HIV: High Value at Minimal Cost.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.0271.
    PubMed    
    
    
    
25. HARRIS E
    Long-Acting HIV Treatment Superior to Daily Oral Drugs.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1570.
    PubMed    
    
    
    
26. MARRAZZO J, Tao L, Becker M, Leech AA, et al
    HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women.
    JAMA. 2024 Mar 1. doi: 10.1001/jama.2024.0464.
    PubMed     Abstract available
    
    
    
27. SAX PE, Thompson MA, Saag MS
    Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel.
    JAMA. 2024 Mar 1. doi: 10.1001/jama.2024.2985.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.